Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001485003-16-000187
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-30 16:12:20
Reporting Period:
2016-09-28
Filing Date:
2016-09-30
Accepted Time:
2016-09-30 16:12:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1485003 Eleven Biotherapeutics Inc. EBIO Pharmaceutical Preparations (2834) 252025616
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590250 Abbie Celniker C/o Eleven Biotherapeutics, Inc.,
215 First Street, Suite 400
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-09-28 10,031 $3.00 409,915 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.
  2. Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $2.92 to $3.04 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of such issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.